Varaico: Literature-Extracted Genetic Variants

Gene:CCND2
Variant:p.T280A
Back to variants list

CCND2

NM_001759.4:p.T280A

Associated Papers

Modeling MPPH syndrome in vivo using Breasi-CRISPR.

Kittock CM et al.

Hgg Advances, 2025

AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression.

Mou J et al.

Journal of Leukocyte Biology, 2025

Mechanism of D-type cyclin recognition by the AMBRA1 E3 ligase receptor.

Wang Y et al.

Science Advances, 2025

A comprehensive benchmark for multiple highly efficient base editors with broad targeting scope.

Wang X et al.

Biorxiv : the Preprint Server for Biology, 2025

39763781 (PubMed )
Supplement: media-3.xlsx › ABE_screen_library

A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome.

Zhao MF et al.

Dna and Cell Biology, 2024

CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases.

Iaquinta G et al.

Leukemia & Lymphoma, 2023

Diagnostic yield and novel candidate genes for neurodevelopmental disorders by exome sequencing in an unselected cohort with microcephaly.

Wang C et al.

Bmc Genomics, 2023

Endosomal trafficking defects alter neural progenitor proliferation and cause microcephaly.

Carpentieri JA et al.

Nature Communications, 2022

Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.

Pirozzi F et al.

American Journal of Medical Genetics. Part A, 2021

Cyclin-dependent kinases and rare developmental disorders.

Colas P

Orphanet Journal of Rare Diseases, 2020

The functional landscape of the human phosphoproteome.

Ochoa D et al.

Nature Biotechnology, 2020

31819260 (PubMed )
Supplement: EMS84831-supplement-Table_S5.xlsx › clinvar_data

Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR.

Dobyns WB et al.

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2019

Systematic analysis of the intersection of disease mutations with protein modifications.

Simpson CM et al.

Bmc Medical Genomics, 2019

31345222 (PubMed )
Supplement: 12920_2019_543_MOESM5_ESM.xlsx › S4

Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.

Koyama T et al.

Bmc Cancer, 2019

30709382 (PubMed )
Supplement: 12885_2019_5313_MOESM3_ESM.xlsx › supplementary_3_filtered

15 years of PhosphoSitePlus®: integrating post-translationally modified sites, disease variants and isoforms.

Hornbeck PV et al.

Nucleic Acids Research, 2019

30445427 (PubMed )
Supplement: gky1159_supplemental_files.xlsx › SupplT1

Genetics and mechanisms leading to human cortical malformations.

Romero DM et al.

Seminars in Cell & Developmental Biology, 2018

Recurrent cyclin D2 mutations in myeloid neoplasms.

Khanna V et al.

Leukemia, 2017

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Eisfeld AK et al.

Leukemia, 2017

De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.

Mirzaa G et al.

Nature Genetics, 2014

PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a.

Zeng N et al.

Aging Cell, 2013

Multiple mechanisms for p27(Kip1) translocation and degradation.

Susaki E et al.

Cell Cycle (georgetown, Tex.), 2007

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."